Dador, Mercedita F.

HRN: 22-86-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2023
CEFUROXIME 1.5GM (VIAL)
04/13/2023
04/19/2023
IV
1.5gm
Q8
Acute Cystitis

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: